Novartis Looks to Combination Alliances to Strengthen its Hepatitis C Therapeutics Pipeline
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 73 (Table of Contents)
Published: 1 Jul-2006
DOI: 10.3833/pdr.v2006.i73.486 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Infection with hepatitis C virus (HCV) is treated with a combination therapy of antiviral drugs and interferon alpha...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS